CDNA
CDNA
US · Stock · NYSE/NASDAQ
$37.61
Pre-Market · NYSE/NASDAQ
AIQ Score (0-100)
64
/100
NEUTRAL
Smart Score (1-10)
10 /10
Momentum81
Value67
Quality59
Risk39

SignalIQ Stock Brief

Published · as of 2026-07-24

The dominant signal within the score vector is the confluence of high Momentum and Timing scores, indicating a technically opportune entry point for current market conditions. The Quality score at 59.0 suggests solid underlying fundamentals, while the Value score of 67.0 indicates reasonable valuation relative to historical metrics. However, the Momentum delta over the last seven days shows a -2.0 change, suggesting recent deceleration in price action that warrants consideration alongside the elevated Timing score. The combination of high Quality (59.0) and moderate Momentum (80.0) suggests that while the underlying quality remains robust, the immediate upward thrust has softened slightly. Furthermore, the Risk score is low at 39.0, providing a buffer against volatility despite the 'VERY HIGH' risk rating derived from other signals. The overall structure points to strong technical readiness and favorable timing (82.0), which may be acting as a counterweight to the recent deceleration in momentum (-2.0). A watch condition is established: If the Momentum score fails to hold above 75.0 on any trading day, it suggests that the current market enthusiasm may not be sustainable, regardless of the high Timing reading.

Summary ▸

The score vector exhibits a notable divergence between high Momentum (80.0) and elevated Timing (82.0), suggesting current market positioning is highly favorable despite recent cooling in momentum metrics. This combination implies that the stock's technical readiness and immediate market timing are strong, potentially overriding concerns related to short-term velocity changes.

Current market regime: Neutral

In a Neutral regime, CDNA's AIQ Score of 64/100 with Quality base of 59/100 and accelerating Momentum at 81/100 (Δ+1) signals mixed conviction. Wait for component alignment before adding exposure. Watch momentum trend for confirmation or fading.

Signal conflict detected

Momentum (81/100) leads while Quality (59/100) lags. This cross-factor spread creates entry timing uncertainty. Wait for the lagging factor to begin recovering before adding aggressively.

Why CDNA scores 64 — top signal drivers
Golden Cross Active
high-impact trend signal at 29.69% supporting upside conditions: Golden Cross Active.
bullish+76.00%
ATR Expansion - Breakout Mode
medium-impact volatility signal at 5.05% worth monitoring: ATR Expansion - Breakout Mode.
neutral+68.00%
Keltner Channel Breakout
medium-impact volatility signal at 37.61 supporting upside conditions: Keltner Channel Breakout.
bullish+68.00%
RSI Overbought
medium-impact momentum signal at 72.5 warning of downside pressure: RSI Overbought.
bearish+68.00%
EMA Ribbon Expansion Bullish
medium-impact trend signal at 3.544 supporting upside conditions: EMA Ribbon Expansion Bullish.
bullish+68.00%
Healthcare·sector move·Market context unavailable.

Quick Stats

Market Cap
P/E Ratio
P/B Ratio
Dividend Yield
Beta
Volume
52W High
52W Low
Evidence Receipts + Persistence
AIQ score today
64/100
Neutral
30-day Avg AIQ
63/100
-1 vs today — trending up
Days with AIQ ≥ 60 (last 60)
56 of 60 trading days
Strongest driver
Momentum 81/100 — top-tier
Binding constraint
Risk 39/100 — weak
7-day momentum Δ
+1 pts — stable
AIQ Score Change Narrative

CDNA's 7-day signal profile is largely stable with AIQ change of 0.0 points and momentum delta of +1.0. Trend delta is 0.00, which helps frame whether the current move is accelerating or fading.

Snapshot: Thu, 23 Jul 2026 00:00:00 GMT. Baseline: 2026-07-16.

AIQ Δ7d: 0.0Momentum Δ7d: +1.0Value Δ7d: 0.0Quality Δ7d: 0.0Risk Δ7d: -1.0Trend Δ7d: 0.00
Score Historymethodology →
DateAIQMomValQualRisk
2026-07-236481675939
2026-07-226481675939
2026-07-216482675939
2026-07-206482675939
2026-07-186482675939
Recent News
See all news
Sentiment —
No recent news found for CDNA

CDNA (CDNA) Stock Analysis

Snapshot summary of AIQ score, trend, and risk context.

CDNA (CDNA) has an AIQ Score of 64/100 in a Neutral regime as of Jul 23, 2026. Momentum is strongest at 81/100. Risk is weakest at 39/100. The main conflict is that momentum leads at 81/100 while risk lags at 39/100.

CDNA (CDNA) carries an AIQ Score of 64 out of 100, placing it in a mixed signal regime for this snapshot. A mid-range reading typically means component signals are not fully aligned, so interpretation should focus on what is improving versus what is lagging.

Beta is 2.58, implying roughly 159% higher sensitivity than a broad market baseline.

In the latest weekly profile, AIQ has moved 0.0 points over the last 7 days, momentum delta is +1.0, trend delta is 0.00, risk delta is -1.0. This combination is most useful for judging whether signal quality is strengthening or fading into mean reversion.

Evidence LayerPublic Evidence
Regime ContextCDNA is in a Neutral AIQ regime with score 64/100.
Signal ConflictThe primary conflict is that momentum leads at 81/100 while risk lags at 39/100.
Factor EvidenceMomentum 81/100 · Value 67/100 · Quality 59/100 · Risk 39/100
PersistenceCDNA has scored AIQ 60+ in 56 of the last 60 daily snapshots. 30-day avg: 63/100. 60-day avg: 62/100.
ChecklistStatusEvidence
Factor strengthPassMomentum is the strongest factor at 81/100.
TimingPassMomentum is 81/100 with 7-day delta +1.0.
Regime fitPassCDNA is in a Neutral regime at 64/100.
Risk controlPassRisk factor is 39/100 with beta of 2.58 indicates above-market sensitivity.
ConflictWaitCurrent conflict: momentum leads at 81/100 while risk lags at 39/100.
AIQ 60+ snapshots: 56/60
30-snapshot avg: 63/100
60-snapshot avg: 62/100
What Changed Recently (CDNA)

CDNA's 7-day signal profile is largely stable with AIQ change of 0.0 points and momentum delta of +1.0. Trend delta is 0.00, which helps frame whether the current move is accelerating or fading.

Signal snapshot as of Thu, 23 Jul 2026 00:00:00 GMT. 7-day comparison baseline: 2026-07-16.

AIQ Δ7d: 0.0
Momentum Δ7d: +1.0
Value Δ7d: 0.0
Quality Δ7d: 0.0
Risk Δ7d: -1.0
Trend Δ7d: 0.00
MetricCurrent
AIQ Score64/100
Price$37.61
Beta2.58

CDNA vs Technology Peers

CDNA ranks 1 of 5 in this peer set. Full sector ranking →
Compare Stocks
SymbolAIQSmartVerdict
CDNA6410Neutral
AAPL6310Neutral
MSFT619Neutral
META568Neutral
GOOGL526Neutral

Portfolio Implication

CDNA currently shows balanced but still concentration-sensitive risk. Beta is currently unavailable, so position sizing should be reviewed with scenario analysis.

CDNA Stock FAQ

What does the CDNA AIQ Score mean?

AIQ Score summarizes multiple factors for CDNA, including momentum, value, quality, and risk. Higher scores generally indicate stronger combined signals, but you should still validate with your own risk tolerance.

How often is CDNA data updated?

CDNA quote and scoring components refresh on the platform cadence. Always confirm timestamp freshness on-page before making time-sensitive decisions.

Should I compare CDNA with an index before investing?

Yes. Comparing CDNA versus benchmarks like SPY or QQQ helps you separate stock-specific strength from broader market moves.

Where can I review deeper CDNA fundamentals, technicals, and risk?

Use the Fundamentals, Technicals, and Risk tabs from this page to inspect driver-level metrics behind the headline score.

How the AIQ Score Is Built

Methodology, factor weights, and how to interpret score history

Read the methodology →

Loading CDNA...

© 2026 AlgoVestIQTermsPrivacyRisk Disclosure

Informational only, not investment advice. Investing involves risk, including loss of principal.